Myeloma Center

Bibliography

Found 1 results
Author Title [ Type(Desc)] Year
Filters: Author is Tegnestam, Linda and Keyword is Maximum Tolerated Dose  [Clear All Filters]
Journal Article
Mark TM, Guarneri D, Forsberg P, Rossi A, Pearse R, Perry A, Pekle K, Tegnestam L, Greenberg J, Shore T et al..  2017.  A Phase I Trial of High-Dose Lenalidomide and Melphalan as Conditioning for Autologous Stem Cell Transplantation in Relapsed or Refractory Multiple Myeloma.. Biol Blood Marrow Transplant. 23(6):930-937.